Use of Monophosphoryl Lipid A as a Prophylactic for Sepsis and Shock
Of patients who ultimately develop gram-negative sepsis and shock, many can be identified for inclusion into high-risk groups [1–3]. These groups include patients subjected to certain types of surgeries, some with traumatic injuries, and those with depressed immune systems. Appropriate immunomodulation of patients in these groups should be able to prevent or ameliorate septic shock.
KeywordsSeptic Shock Continuous Ambulatory Peritoneal Dialysis Endotoxin Tolerance Monophosphoryl Lipid Serum Neopterin
Unable to display preview. Download preview PDF.
- 4.Rudbach JA, Cantrell JL, Ulrich JT, Mitchell MS (1990) Immunotherapy with bacterial endotoxins. In: Friedman H, Klein TW, Nakaro M, Nowatny A (eds) Endotoxin. Plenum, New York, pp 665–676Google Scholar
- 9.Ulrich JT, Mashihi KN, Lange W (1988) Mechanisms of nonspecific resistance to microbial infections induced by trehalose dimycolate (TDM) and monophosphoryl lipid A (MPL). Adv Biosci 68:167–178Google Scholar